• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响前列腺癌风险和血浆性类固醇水平的家族因素。

Familial factors affecting prostatic cancer risk and plasma sex-steroid levels.

作者信息

Meikle A W, Smith J A, West D W

出版信息

Prostate. 1985;6(2):121-8. doi: 10.1002/pros.2990060202.

DOI:10.1002/pros.2990060202
PMID:3975174
Abstract

Whether familial factors affect the frequency of prostatic cancer and the plasma content of sex-steroids was investigated. Brothers (n = 257) of probands (n = 150) diagnosed with prostatic cancer before age 62 years had a fourfold higher risk for developing the disease than men in the general population in the State of Utah and their brothers-in-law (n = 202). Familial factors markedly affected the plasma content of sex steroids (testosterone, dihydrotestosterone, the ratio of testosterone to DHT, sex-hormone binding globulin, and the free fraction of testosterone) in nonendocrinologically treated probands and their brothers and sons and in normal men in the general populations. Index cases and their brothers and sons had a significantly lower mean plasma testosterone content than controls of comparable age. Preliminary data suggest that the metabolic clearance rate of testosterone and the conversion ratio of testosterone to estradiol are relatively high in probands. The observations indicate that familial factors are potent risk factors for the development of prostatic cancer. They also suggest that plasma androgen values in families with prostatic cancer cluster in the lower range of normal and that plasma sex-steroid content is more similar in each brothers with or without prostatic cancer than among nonbrothers.

摘要

研究了家族因素是否会影响前列腺癌的发病率以及性类固醇的血浆含量。在犹他州,先证者(n = 150)在62岁之前被诊断患有前列腺癌,其兄弟(n = 257)患该病的风险是普通人群及其姐夫(n = 202)的四倍。家族因素显著影响了未经内分泌治疗的先证者及其兄弟和儿子以及普通人群中正常男性的性类固醇血浆含量(睾酮、双氢睾酮、睾酮与双氢睾酮的比值、性激素结合球蛋白以及睾酮的游离部分)。索引病例及其兄弟和儿子的平均血浆睾酮含量显著低于同龄对照组。初步数据表明,先证者中睾酮的代谢清除率和睾酮向雌二醇的转化率相对较高。这些观察结果表明,家族因素是前列腺癌发生的有力危险因素。它们还表明,前列腺癌家族中的血浆雄激素值聚集在正常范围的较低水平,并且患有或未患有前列腺癌的兄弟之间的血浆性类固醇含量比非兄弟之间更为相似。

相似文献

1
Familial factors affecting prostatic cancer risk and plasma sex-steroid levels.影响前列腺癌风险和血浆性类固醇水平的家族因素。
Prostate. 1985;6(2):121-8. doi: 10.1002/pros.2990060202.
2
Familial prostatic cancer risk and low testosterone.家族性前列腺癌风险与低睾酮水平
J Clin Endocrinol Metab. 1982 Jun;54(6):1104-8. doi: 10.1210/jcem-54-6-1104.
3
Familial effects on plasma sex-steroid content in man: testosterone, estradiol and Sex-hormone-binding globulin.家族对男性血浆性类固醇含量的影响:睾酮、雌二醇和性激素结合球蛋白。
Metabolism. 1982 Jan;31(1):6-9.
4
Production, clearance, and metabolism of testosterone in men with prostatic cancer.前列腺癌男性体内睾酮的产生、清除及代谢
Prostate. 1987;10(1):25-31. doi: 10.1002/pros.2990100106.
5
Prospective study of sex hormone levels and risk of prostate cancer.性激素水平与前列腺癌风险的前瞻性研究。
J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26. doi: 10.1093/jnci/88.16.1118.
6
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.在前列腺特异性抗原时代,性类固醇激素、雄激素受体基因CAG重复序列与前列腺癌后续风险
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9. doi: 10.1158/1055-9965.EPI-04-0371.
7
Quantitating genetic and nongenetic factors that determine plasma sex steroid variation in normal male twins.定量分析决定正常男性双胞胎血浆性类固醇变化的遗传和非遗传因素。
Metabolism. 1986 Dec;35(12):1090-5. doi: 10.1016/0026-0495(86)90020-x.
8
Estradiol and testosterone metabolism and production in men with prostatic cancer.前列腺癌男性患者体内雌二醇和睾酮的代谢与生成
J Steroid Biochem. 1989 Jul;33(1):19-24. doi: 10.1016/0022-4731(89)90352-x.
9
The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.己烯雌酚和醋酸甲羟孕酮对前列腺癌患者睾酮和双氢睾酮动力学及生成的影响。
J Clin Endocrinol Metab. 1976 Dec;43(6):1226-33. doi: 10.1210/jcem-43-6-1226.
10
A study of the endocrine manifestations of hepatic cirrhosis.肝硬化内分泌表现的研究。
Q J Med. 1976 Jan;45(177):145-78.

引用本文的文献

1
Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.基因多态性在散发性和家族性前列腺癌发生发展及预后中的作用
PLoS One. 2016 Dec 1;11(12):e0166380. doi: 10.1371/journal.pone.0166380. eCollection 2016.
2
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.睾酮测量、数据解读及干预试验方法学评估中的挑战。
J Sex Med. 2016 Jul;13(7):1029-46. doi: 10.1016/j.jsxm.2016.04.068. Epub 2016 May 18.
3
Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.
应用有序子集分析研究芬兰遗传性前列腺癌的遗传异质性。
Eur J Hum Genet. 2013 Apr;21(4):437-43. doi: 10.1038/ejhg.2012.185. Epub 2012 Sep 5.
4
Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population.中国人群中17号染色体上单核苷酸多态性与前列腺癌风险的关联。
Chin J Cancer. 2011 Oct;30(10):721-30. doi: 10.5732/cjc.011.10070.
5
The clinical genetics of prostate cancer.前列腺癌的临床遗传学
Hered Cancer Clin Pract. 2004 Jul 15;2(3):111-21. doi: 10.1186/1897-4287-2-3-111.
6
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.前列腺癌的老问题与新方法:第一部分。流行病学、发病率和遗传改变。
Pathol Oncol Res. 1996 Mar;2(1-2):98-109. doi: 10.1007/BF02893960.
7
Associations between coronary heart disease, obesity and histological prostate cancer.冠心病、肥胖与组织学前列腺癌之间的关联。
Int Urol Nephrol. 2007;39(1):197-201. doi: 10.1007/s11255-006-9010-z. Epub 2006 Sep 28.
8
Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring.雄激素补充与前列腺癌风险:治疗前评估与监测策略
Rev Urol. 2003;5 Suppl 1(Suppl 1):S29-33.
9
Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.促黄体生成素释放激素激动剂的挑战:激发和激增。
Rev Urol. 2004;6 Suppl 7(Suppl 7):S12-8.
10
A genome screen of multiplex sibships with prostate cancer.一项针对前列腺癌多重同胞家系的基因组筛查。
Am J Hum Genet. 2000 Mar;66(3):933-44. doi: 10.1086/302818.